Results 91 to 100 of about 1,313 (167)

Sofpironium Bromide for the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Cureus
Martani D, Silva MS, Nakanishi L, Valente LF, Garza-Dueñas GG, Silva MO, Crocco EI.   +6 more
europepmc   +1 more source

Three-Year Results Following Microwave Therapy in Patients with Severe Primary Axillary Hyperhidrosis. [PDF]

Aesthetic Plast Surg
Micu E, Fragkou Dragka M, Shayesteh A.
europepmc   +1 more source

A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. [PDF]

J Dermatol, 2021
Yokozeki H, Fujimoto T, Abe Y, Igarashi M, Ishikoh A, Omi T, Kanda H, Kitahara H, Kinoshita M, Nakasu I, Hattori N, Horiuchi Y, Maruyama R, Mizutani H, Murakami Y, Watanabe C, Kume A, Hanafusa T, Hamaguchi M, Yoshioka A, Egami Y, Matsuo K, Matsuda T, Akamatsu M, Yorozuya T, Takayama S.   +25 more
europepmc   +1 more source

Axillary Skin Excision for Axillary Hyperhidrosis

International Journal of Clinical Practice, 1981
openaire   +2 more sources

Sofpironium bromide: a novel solution in the battle against primary axillary hyperhidrosis. [PDF]

Ann Med Surg (Lond)
Rashmeen S, Sohail I, Mohsin M, Anwar D, Farhat S, Shahnoor S, Maryyum A, Khan AM.   +7 more
europepmc   +1 more source

Efficacy and Safety of Botulinum Toxin Type A in Primary Axillary Hyperhidrosis: A Meta-analysis and Systematic Review. [PDF]

Aesthetic Plast Surg
Sun J, Chen S, Yang T, Huang L, Tang J, Feng Y, Yu Q, Wang Y, Luo Y, Tang Y, Gao L.   +10 more
europepmc   +1 more source

Seasonal Variation and Meteorological Correlates of Botulinum Toxin Injections for Axillary Hyperhidrosis in Japan: A Retrospective Analysis. [PDF]

Cureus
Kabata Y.
europepmc   +1 more source

Thoracoscopic sympathicotomy for the treatment of intolerable palmar and axillary hyperhidrosis in children is associated with high recurrence rates. [PDF]

Pediatr Dermatol, 2020
Verhaegh AJFP, Kuijpers M, Boon M, DeJongste MJL, Bouma W, Mariani MA, Klinkenberg TJ.   +6 more
europepmc   +1 more source

Topical oxybutynin deodorant for axillary hyperhidrosis: a topic or a systemic effect? Rationale and design of the phase II today trial. [PDF]

J Vasc Bras
Neves S, Volpiani GG, Paganotti A, Menegueti F, Boix RS, Caffaro RA, Dos Santos VP, Ramacciotti E.   +7 more
europepmc   +1 more source

Correction to: Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use. [PDF]

Clin Drug Investig, 2020
Lamb YN.
europepmc   +1 more source